Synergistic Interaction of the Class IIa HDAC Inhibitor CHDI0039 with Bortezomib in Head and Neck Cancer Cells.

Schrenk C, Bollmann LM, Haist C, Bister A, Wiek C, Wecker M, Roth D, Petzsch P, Kohrer K, Hamacher A, Hanenberg H, Fluegen G, Kassack MU
Int J Mol Sci. 2023 Mar 14;24(6):5553. doi: 10.3390/ijms24065553. PubMed Article

Plasmids from Article

No plasmids are currently publicly available from Addgene for this article.